Epidemiology of Pertussis and Pertussis-Related Complications in Adults: A German Claims Data Analysis.

Comorbidity Incidence Older adults Pertussis Real world evidence Risk factor Whooping cough

Journal

Infectious diseases and therapy
ISSN: 2193-8229
Titre abrégé: Infect Dis Ther
Pays: New Zealand
ID NLM: 101634499

Informations de publication

Date de publication:
31 Jan 2024
Historique:
received: 17 09 2023
accepted: 20 12 2023
medline: 31 1 2024
pubmed: 31 1 2024
entrez: 31 1 2024
Statut: aheadofprint

Résumé

Pertussis is a highly contagious respiratory infection. It affects people of all ages, yet evidence of the impact of pertussis in adults with underlying conditions (UCs) is scarce. This study investigated the incidence and complication rate of pertussis in adult patients with and without UC. A retrospective analysis was conducted using routinely collected German claims data between 2015 and 2019. Patients with and without different pneumological, cardiovascular, endocrinological, musculoskeletal, and psychological UCs were matched for incidence estimation. Logistic regression models were used to estimate the risk of pertussis depending on the presence of UCs. Negative binomial models were used to assess complication rates in patients with pertussis and with and without UC. In total, 4383 patients were diagnosed with pertussis during the study period. Patients with any UC had an increased risk for pertussis compared to matched patients without UC (odds ratio [OR] 1.72; 95% confidence interval [CI]1.60-1.84, p < 0.0001). Underlying asthma had the highest risk of pertussis (OR 2.70; 95% CI 2.50-2.91, p < 0.0001), followed by chronic obstructive pulmonary disease (OR 2.35; 95% CI 2.10-2.60, p < 0.0001) and depression (OR 2.08; 95% CI 1.95-2.22, p < 0.0001). Severe complications occurred in 10.8% of the pertussis cohort (13.4% with UC vs. 9.5% without UC). The UC-attributable effect on the risk of severe pertussis-related complications was significantly increased for any UC (incidence rate ratio [IRR] 1.29, 95% CI 1.19-1.39). The severe complication risk was also increased for patients aged 60+ (IRR 1.59, 95% CI 1.46-1.72). This study shows that adults with certain UCs have an increased risk for pertussis and are more likely to have complications. These results provide further evidence that pertussis is a relevant and impactful infectious disease in adults with and without certain UC, indicating that these patients need to be considered when developing vaccination recommendations to avoid pertussis and its associated complications. A graphical abstract is available with this article.

Identifiants

pubmed: 38294623
doi: 10.1007/s40121-023-00912-z
pii: 10.1007/s40121-023-00912-z
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

© 2024. The Author(s).

Références

Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326–82. https://doi.org/10.1128/CMR.18.2.326-382.2005 .
doi: 10.1128/CMR.18.2.326-382.2005 pubmed: 15831828 pmcid: 1082800
Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis. 2001;32(12):1691–7. https://doi.org/10.1086/320754 .
doi: 10.1086/320754 pubmed: 11360208
Robert Koch-Institut. Epidemiologisches Bulletin: Impfquoten bei Erwachsenen in Deutschland; 2022. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/49_22.html . Accessed 6 Mar 2033.
Jenkins VA, Savic M, Kandeil W. Pertussis in high-risk groups: an overview of the past quarter-century. Hum Vaccin Immunother. 2020;16(11):2609–17. https://doi.org/10.1080/21645515.2020.1738168 .
doi: 10.1080/21645515.2020.1738168 pubmed: 32298213 pmcid: 7746252
Schielke A, Takla A, von Kries R, Wichmann O, Hellenbrand W. Marked underreporting of pertussis requiring hospitalization in infants as estimated by capture-recapture methodology, Germany, 2013–2015. Pediatr Infect Dis J. 2018;37(2):119–25. https://doi.org/10.1097/INF.0000000000001698 .
doi: 10.1097/INF.0000000000001698 pubmed: 28723872
Kandeil W, Atanasov P, Avramioti D, Fu J, Demarteau N, Li X. The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. Expert Rev Vaccines. 2019;18(5):439–55. https://doi.org/10.1080/14760584.2019.1588727 .
doi: 10.1080/14760584.2019.1588727 pubmed: 30887849
McGuiness CB, Hill J, Fonseca E, Hess G, Hitchcock W, Krishnarajah G. The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study. BMC Infect Dis. 2013;13:32. https://doi.org/10.1186/1471-2334-13-32 .
doi: 10.1186/1471-2334-13-32 pubmed: 23343438 pmcid: 3610269
Macina D, Evans KE. Pertussis in individuals with co-morbidities: a systematic review. Infect Dis Ther. 2021;10(3):1141–70. https://doi.org/10.1007/s40121-021-00465-z .
doi: 10.1007/s40121-021-00465-z pubmed: 34117998 pmcid: 8322178
Robert Koch-Institut. SurvStat@RKI 2.0. 2023. https://survstat.rki.de/ . Accessed 21 Nov 2023.
Swart E, Gothe H, Geyer S, et al. Gute Praxis Sekundärdatenanalyse (GPS): leitlinien und empfehlungen. Gesundheitswesen. 2015;77(2):120–6. https://doi.org/10.1055/s-0034-1396815 .
doi: 10.1055/s-0034-1396815 pubmed: 25622207
Busse R, Blümel M, Knieps F, Bärnighausen T. Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet. 2017;390(10097):882–97. https://doi.org/10.1016/S0140-6736(17)31280-1 .
doi: 10.1016/S0140-6736(17)31280-1 pubmed: 28684025
Bundesministerium für Gesundheit. Mitglieder und Versicherte der Gesetzlichen Krankenversicherung (GKV): Statistik uber Versicherte, gegliedert nach Status, Alter, Wohnort und Kassenart; 2020. https://www.bundesgesundheitsministerium.de/themen/krankenversicherung/zahlen-und-fakten-zur-krankenversicherung/mitglieder-und-versicherte . Accessed 21 Nov 2023.
Aris E, Harrington L, Bhavsar A, et al. Burden of pertussis in COPD: a retrospective database study in England. COPD. 2021;18(2):157–69. https://doi.org/10.1080/15412555.2021.1899155 .
doi: 10.1080/15412555.2021.1899155 pubmed: 33866914
Harrington L, Aris E, Bhavsar A, et al. Burden of pertussis in adults aged 50 years and older: a retrospective database study in England. Infect Dis Ther. 2023;12(4):1103–18. https://doi.org/10.1007/s40121-023-00774-5 .
doi: 10.1007/s40121-023-00774-5 pubmed: 36966230 pmcid: 10147870
Karki S, McIntyre P, Newall AT, MacIntyre CR, Banks E, Liu B. Risk factors for pertussis hospitalizations in Australians aged 45 years and over: a population based nested case-control study. Vaccine. 2015;33(42):5647–53. https://doi.org/10.1016/j.vaccine.2015.08.068 .
doi: 10.1016/j.vaccine.2015.08.068 pubmed: 26335770
Bhavsar A, Aris E, Harrington L, et al. Burden of pertussis in individuals with a diagnosis of asthma: a retrospective database study in England. J Asthma Allergy. 2022;15:35–51. https://doi.org/10.2147/JAA.S335960 .
doi: 10.2147/JAA.S335960 pubmed: 35046668 pmcid: 8760990
Buck PO, Meyers JL, Gordon L-D, Parikh R, Kurosky SK, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims. Epidemiol Infect. 2017;145(10):2109–21. https://doi.org/10.1017/S0950268817000887 .
doi: 10.1017/S0950268817000887 pubmed: 28462763 pmcid: 5968309
Capili CR, Hettinger A, Rigelman-Hedberg N, et al. Increased risk of pertussis in patients with asthma. J Allergy Clin Immunol. 2012;129(4):957–63. https://doi.org/10.1016/j.jaci.2011.11.020 .
doi: 10.1016/j.jaci.2011.11.020 pubmed: 22206778
Del Cid FJ, Salazar M, Argueta-Sosa EE. Vaccine-preventable disease hospitalized patients with heart failure with reduced ejection fraction. Clin Cardiol. 2022;45(5):474–81. https://doi.org/10.1002/clc.23800 .
doi: 10.1002/clc.23800
Liu BC, McIntyre P, Kaldor JM, Quinn HE, Ridda I, Banks E. Pertussis in older adults: prospective study of risk factors and morbidity. Clin Infect Dis. 2012;55(11):1450–6. https://doi.org/10.1093/cid/cis627 .
doi: 10.1093/cid/cis627 pubmed: 22806592
Wolter N, Cohen C, Tempia S, et al. Epidemiology of pertussis in individuals of all ages hospitalized with respiratory illness in South Africa, January 2013–December 2018. Clin Infect Dis. 2021;73(3):e745–53. https://doi.org/10.1093/cid/ciab089 .
doi: 10.1093/cid/ciab089 pubmed: 33530100
De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182(1):174–9. https://doi.org/10.1086/315648 .
doi: 10.1086/315648 pubmed: 10882595
Leong RNF, Wood JG, Liu B, McIntyre PB, Newall AT. High healthcare resource utilisation due to pertussis in Australian adults aged 65 years and over. Vaccine. 2020;38(19):3553–9. https://doi.org/10.1016/j.vaccine.2020.03.021 .
doi: 10.1016/j.vaccine.2020.03.021 pubmed: 32220516
Kim H, Shin J-Y, Chen J, et al. Risk factors of pertussis among older adults in South Korea: a nationwide health data-based case-control study. Infect Dis Ther. 2023;12(2):545–61. https://doi.org/10.1007/s40121-022-00747-0 .
doi: 10.1007/s40121-022-00747-0 pubmed: 36588139 pmcid: 9925654
Clarke MF, Rasiah K, Copland J, et al. The pertussis epidemic: informing strategies for prevention of severe disease. Epidemiol Infect. 2013;141(3):463–71. https://doi.org/10.1017/S095026881200091X .
doi: 10.1017/S095026881200091X pubmed: 22595516
Skoff TH, Hadler S, Hariri S. The epidemiology of nationally reported pertussis in the United States, 2000–2016. Clin Infect Dis. 2019;68(10):1634–40. https://doi.org/10.1093/cid/ciy757 .
doi: 10.1093/cid/ciy757 pubmed: 30169627
Kern DM, Davis J, Williams SA, et al. Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population. Int J Chron Obstruct Pulmon Dis. 2015;10:1417–25. https://doi.org/10.2147/COPD.S83135 .
doi: 10.2147/COPD.S83135 pubmed: 26229461 pmcid: 4516198
Kreis K, Neubauer S, Klora M, Lange A, Zeidler J. Status and perspectives of claims data analyses in Germany—a systematic review. Health Policy. 2016;120(2):213–26. https://doi.org/10.1016/j.healthpol.2016.01.007 .
doi: 10.1016/j.healthpol.2016.01.007 pubmed: 26826756
Batram M, Witte J, Schwarz M, et al. Burden of herpes zoster in adult patients with underlying conditions: analysis of German Claims Data, 2007–2018. Dermatol Ther (Heidelb). 2021;11(3):1009–26. https://doi.org/10.1007/s13555-021-00535-7 .
doi: 10.1007/s13555-021-00535-7 pubmed: 33959878

Auteurs

Bastian Surmann (B)

Vandage GmbH, Detmolder Straße 30, 33604, Bielefeld, Germany.

Julian Witte (J)

Vandage GmbH, Detmolder Straße 30, 33604, Bielefeld, Germany. julian.witte@vandage.de.

Manuel Batram (M)

Vandage GmbH, Detmolder Straße 30, 33604, Bielefeld, Germany.

Carl Peter Criée (CP)

Department of Sleep and Respiratory Medicine, Evangelical Hospital Goettingen-Weende, Bovenden, Germany.

Christiane Hermann (C)

Department of Clinical Psychology, Justus-Liebig University Giessen, Giessen, Germany.

Andreas Leischker (A)

Department for Geriatrics, Working Group "Vaccination", German Geriatric Society, Cologne, Germany.
Asklepios Hospital Wandsbek, Hamburg, Germany.

Jörg Schelling (J)

Medizinische Klinik IV, Ludwig-Maximilians-University Munich, Munich, Germany.

Mirko Steinmüller (M)

PRAXIS DILLTAL, Ehringshausen, Germany.

Klaus Wahle (K)

Department of General Medicine, University of Muenster, Muenster, Germany.

Alexander F Heiseke (AF)

GSK, Munich, Germany.

Classifications MeSH